1 дек. 2019 г. · The risk of bleeding was also lower for clopidogrel versus aspirin (0.57 [0.45, 0.74]). There was no difference in the rate of all-cause ...

15 авг. 2023 г. · 4. The absolute increase in the incidence of major bleeding with aspirin vs. clopidogrel is relatively small. Future Studies. Although ...

A recent meta-analysis comparing the safety of aspirin with a P2Y12 inhibitor found higher rates of GI bleeding with aspirin (1.56% vs 1.22%; odds ratio [OR]: ... Skip main navigation · Introduction

7 нояб. 2022 г. · Clopidogrel monotherapy was associated with a lower risk in both thrombotic end points and bleeding end points with no significant difference in ...

The safety outcomes suggested clopidogrel could drop the risk of BARC major bleeding down, compared with the aspirin group. Moreover, using aspirin or ...

Clopidogrel users also had lower risks of intracranial hemorrhage and the composite major bleeding events compared with aspirin users.

10 янв. 2023 г. · Clopidogrel monotherapy was associated with a lower risk in both thrombotic end points and bleed- ing end points with no significant difference ...

22 часа назад · This study compares clopidogrel vs aspirin monotherapy in patients with high bleeding risk and/or percutaneous coronary intervention ...

30 мар. 2022 г. · There was no difference in the risk of major bleeding or any bleeding between P2Y12 inhibitor and aspirin monotherapy, and the risk of major ...